NEUPATH HEALTH INC
看多

NPTH.V - Biomed/telehealth stock trading below 1x revenues

113
NPTH is significantly undervalued compared to peers:
- $33M mkt cap with $50M revenue in 2019
- < 1 EV/sales vs 18.24x industry avg
- Recent $12M financing at .90
- Insider options at .87 + open market buys
- In major historical support zone

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。